MediWound Ltd (MDWD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges [Yahoo! Finance]
MediWound Ltd. - Ordinary Shares (MDWD)
Last mediwound ltd. - ordinary shares earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.mediwound.com/press-releases
Company Research
Source: Yahoo! Finance
R&D Expenses (Q3 2024): $2.5 million, up from $1.5 million in Q3 2023. Total Revenue (First 9 Months 2024): $14.4 million, up from $13.3 million in the same period of 2023. Gross Profit (First 9 Months 2024): $1.7 million, or 12% of total revenue, compared to $2.9 million or 21% in the first nine months of 2023. Operating Loss (First 9 Months 2024): $13.3 million, compared to $11.4 million in the same period of 2023. Net Loss (First 9 Months 2024): $26.3 million or $2.72 per share, compared to $5 million or $0.56 per share in the same period of 2023. Adjusted EBITDA (First 9 Months 2024): Loss of $9.9 million, compared to a loss of $9 million in the same period last year. Cash Position (As of September 30, 2024): $46 million, up from $42.1 million at year-end 2023. Strategic Funding: Raised $25 million through a private investment led by Molnlycke Healthcare. Warning! GuruFocus has detected 6 Warning Signs with MDWD. Release Date: November 26, 2024 For the complet
Show less
Read more
Impact Snapshot
Event Time:
MDWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDWD alerts
High impacting MediWound Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MDWD
News
- MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025 [Yahoo! Finance]Yahoo! Finance
- MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025GlobeNewswire
- MediWound Ltd. (NASDAQ: MDWD) had its price target lowered by analysts at HC Wainwright from $28.00 to $25.00. They now have a "buy" rating on the stock.MarketBeat
- MediWound (MDWD) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update [Yahoo! Finance]Yahoo! Finance
MDWD
Earnings
- 11/26/24 - Miss
MDWD
Analyst Actions
- 10/11/24 - HC Wainwright
MDWD
Sec Filings
- 12/19/24 - Form 6-K
- 12/16/24 - Form 6-K
- 11/26/24 - Form 6-K
- MDWD's page on the SEC website